Observation of Clinical Efficacy on Cerebral Infarction Treated with Naoxintong

Objective To explore the clinical efficacy on cerebral infarction treated with buchang naoxintong capsules.Methods 120 cases were randomized into a treatment group and a control group.On the basis of the conventional treatment,buchang naoxintong capsules were added in treatment group.The conventional treatment was applied to control group.14-day treatment made 1 session.The efficacy was assessed at the end of treatment session.Results Concerning to nerve function defect score and Chinese medicine pattern/syndrome score after treatment,the results presented statistical significant difference in comparison between two groups(P0.05).Conclusion The increases in blood lipid,blood glucose and blood viscosity as well as blood flow resistance result in cerebral atherosclerosis.The cerebral atherosclerosis is the main cause of cerebral infarction.In treatment of ischemic apoplexy,the microcirculation should be promoted with thrombolytic and anticoagulant therapy specially and blood pressure should be stabilized by reducing intracranial pressure.It is verified in treatment that naoxintong resists on oxygenic free radical damage,reduces excitatory amino acid level in the brain tissue and alleviates the brain edema.It apparently increases blood flow and reduces blood vascular resistance in the brain.The treatment recovers nerve system of the brain and improves in the physical signs of nerve system such as the motor and speech control.Buchang naoxintong capsules achieve the significant therapeutic effect on acute cerebral infarction.